Oral inflammation and bacteremia: Implications for chronic and acute systemic diseases involving major organs

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 15, Issue 1, 2015, Pages 70-84

  Hirschfeld, Josefine ^a   Kawai, Toshihisa ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b FORSYTH INSTITUTE   (United States)

Author keywords

Bacteremia; Endotoxemia; Endotoxin; Gingivitis; Inflammation; Periodontitis; Systemic disease

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CETYLPYRIDINIUM SALT; CHLORHEXIDINE; CLARITHROMYCIN; CLINDAMYCIN; ESSENTIAL OIL; HYDROGEN PEROXIDE; POVIDONE IODINE; TRICLOSAN;

ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENDOTOXEMIA; GINGIVITIS; HUMAN; KIDNEY DISEASE; LIVER DISEASE; METABOLIC DISORDER; MOUTH INFLAMMATION; NONHUMAN; PERIODONTITIS; PERIPROSTHETIC JOINT INFECTION; RHEUMATOID ARTHRITIS; SYSTEMIC DISEASE; TOOTH PLAQUE; ACUTE DISEASE; ANIMAL; BIOFILM; CHRONIC DISEASE; COMPLICATION; INFLAMMATION; MICROBIOLOGY;

ACUTE DISEASE; ANIMALS; BACTEREMIA; BIOFILMS; CHRONIC DISEASE; DENTAL PLAQUE; GINGIVITIS; HUMANS; INFLAMMATION; PERIODONTITIS;

EID: 84930898805     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X15666150108115241     Document Type: Article

References (153)

1. Lockhart, P.B.; Brennan, M.T.; Thornhill, M.; Michalowicz, B.S.; Noll, J.; Bahrani-Mougeot, F.K.; Sasser, H.C. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J. Am. Dent. Assoc., 2009, 140(10), 1238-44.
2. Aas, J.A.; Paster, B.J.; Stokes, L.N.; Olsen, I.; Dewhirst, F.E. Defining the Normal Bacterial Flora of the Oral Cavity. J. Clin. Microbiol., 2005, 43(11), 5721-5732.
3. Poveda-Roda, R.; Jiménez, Y.; Carbonell, E., Gavaldá, C.; Margaix-Muñoz, M.M.; Sarrión-Pérez, G. Bacteremia originating in the oral cavity. A review. Med. Oral Patol. Oral Cir. Bucal., 2008, 13(6), E355-362.
4. Honda, T.; Domon, H.; Okui, T.; Kajita, K.; Amanuma, R.; Yamazaki, K. Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clin. Exp. Immunol., 2006, 144(1), 35-40.
5. Alexander, C.; Rietschel E.T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res., 2001, 7(3), 167-202.
6. Rosen, P.S. American Academy of Periodontology-Research, Scicence and therapy Committee. Treatment of plaque-induced gingivitis, chronic periodontitis, and clinical conditions. Pediatr. Dent., 2008-2009, 30(7), 253-262.
7. Theilade E. The experimentalgingivitis studies: the microbiological perspective. J. Dent. Res., 1996, 75(7), 1434-1438.
8. Wyss, C.; Moter, A.; Choi, B.K.; Dewhirst, F.E.; Xue, Y.; Schüpbach, P.; Göbel, U.B.; Paster, B.J.; Guggenheim, B. Treponema putidum sp. nov., a medium-sized proteolytic spirochaete isolated from lesions of human periodontitis and acute necrotizing ulcerative gingivitis. Int. J. Syst. Evol. Microbiol., 2004, 54(Pt 4), 1117-1122.
9. Feller, L.; Khammissa, RA.; Wood, NH.; Meyerov, R.; Pantanowitz, L.; Lemmer, J. Oral ulcers and necrotizing gingivitis in relation to HIV-associated neutropenia: a review and an illustrative case. AIDS Res. Hum. Retroviruses., 2012, 28(4), 346-351.
10. Baumgartner, A.; Thurnheer, T.; Lüthi-Schaller, H.; Gmür, R.; Belibasakis, G.N. The phylum Synergistetes in gingivitis and necrotizing ulcerative gingivitis. J. Med. Microbiol., 2012, 61(Pt 11), 1600-1609.
11. Persson, G.R. Rheumatoid arthritis and periodontitis-inflammatory and infectious connections. Review of the literature. J. Oral Microbiol., 2012.
12. Ryan, M.E.; Golub, L.M. Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy. Periodontol., 2000, 10(24), 226-238.
13. Kajiya, M.; Giro, G.; Taubman, M.A.; Han, X.; Mayer, M.P.; Kawai T. Role of periodontal pathogenic bacteria in RANKLmediated bone destruction in periodontal disease. J. Oral Microbiol., 2010.
14. Han, X.; Lin, X.; Seliger, A.R.; Eastcott, J.; Kawai, T.; Taubman, M.A. Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. Oral Microbiol. Immunol., 2009, 24(3), 190-196.
15. Grossi, S.G. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann. Periodontol., 2001, 6(1), 138-145.
16. Fine, D.H.; Markowitz, K.; Furgang, D.; Fairlie, K.; Ferrandiz, J.; Nasri, C.; McKiernan, M.; Gunsolley, J. Aggregatibacter actinomycetemcomitans and its relationship to initiation of localizedaggressiveperiodontitis: longitudinalcohortstudy of initiallyhealthyadolescents. J. Clin. Microbiol., 2007, 45(12), 3859-3869.
17. Ishikawa, I.; Nakashima, K.; Koseki, T.; Nagasawa, T.; Watanabe, H.; Arakawa, S.; Nitta, H.; Nishihara, T. Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol., 1997, 6(14), 79-111.
18. Chung, A.; Kudlick, E.M.; Gregory, J.E.; Royal, G.C.; Reindorf, C.A. Toothbrushing and transient bacteremia in patients undergoing orthodontic treatment. Am. J. Orthod. Dentofacial Orthop., 1986, 90(3), 181-186.
19. Ashare, A.; Stanford, C.; Hancock, P.; Stark, D.; Lilli, K.; Birrer, E.; Nymon, A.; Doerschug, K.C.; Hunninghake, G.W. Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia. Clin. Transl. Sci., 2009, 2(3), 199-205.
20. Levy, M.M.; Fink, M.P.; Marshall, J.C.; Abraham, E.; Angus, D.; Cook, D.; Cohen, J.; Opal, S.M.; Vincent, J.L.; Ramsay, G.; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med., 2003, 31(4), 1250-1256.
21. Brun-Buisson, C.; Doyon, F., Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am. J. Respir. Crit. Care Med., 1996, 154(3 Pt 1), 617-624.
22. Forner, L.; Larsen, T.; Kilian, M.; Holmstrup, P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J. Clin. Periodontol., 2006, 33(6), 401-407.
23. Lucas, V.S.; Gafan, G.; Dewhurst, S.; Roberts, G.J. Prevalence, intensity and nature of bacteraemia after toothbrushing. J. Dent., 2008, 36(7), 481-487.
24. Kinane, D.F.; Riggio, M.P.; Walker, K.F.; MacKenzie, D.; Shearer, B. Bacteraemia following periodontal procedures. J. Clin. Periodontol., 2005, 32(7), 708-713.
25. Tomás, I.; Diz, P.; Tobías, A.; Scully, C.; Donos, N. Periodontal health status and bacteraemia from daily oral activities: systematic review/meta-analysis. J. Clin. Periodontol., 2012, 39(3), 213-28.
26. Matthews, D. Impact of everyday oral activities on the risk of bacteraemia is unclear. Evid. Based Dent., 2012, 13(3), 80.
27. Murphy, A.M.; Daly, C.G.; Mitchell, D.H.; Stewart, D.; Curtis, B.H. Chewing fails to induce oral bacteraemia in patients with periodontal disease. J. Clin. Periodontol., 2006, 33(10), 730-736.
28. Kennedy, H.F.; Morrison, D.; Tomlinson, D.; Gibson, B.E.; Bagg, J.; Gemmell, C.G. Gingivitis and toothbrushes: potential roles in viridans streptococcal bacteraemia. J. Infect., 2003, 46(1), 67-70.
29. Hunter, K.M.; Holborow, D.W.; Kardos, T.B.; Lee-Knight, C.T.; Ferguson, M.M. Bacteraemia and tissue damage resulting from air polishing. Br. Dent. J., 1989, 167(8), 275-278.
30. Carroll, G.C.; Sebor, R.J. Dental flossing and its relationship to transient bacteremia. J. Periodontol., 1980, 51(12), 691-692.
31. Lockhart, P.B.; Brennan, M.T.; Sasser, H.C.; Fox, P.C.; Paster, B.J.; Bahrani-Mougeot, F.K. Bacteremia associated with toothbrushing and dental extraction. Circulation, 2008, 117(24), 3118-3125.
32. Bhanji, S.; Williams, B.; Sheller, B.; Elwood, T.; Mancl, L. Transient bacteremia induced by toothbrushing a comparison of the Sonicare toothbrush with a conventional toothbrush. Pediatr. Dent., 2002, 24(4), 295-299.
33. Schlein, R.A.; Kudlick, E.M.; Reindorf, C.A.; Gregory, J.; Royal, G.C. Toothbrushing and transient bacteremia in patients undergoing orthodontic treatment. Am. J. Orthod. Dentofacial Orthop., 1991, 99(5), 466-472.
34. Maharaj, B.; Coovadia, Y.; Vayej, A.C. An investigation of the frequency of bacteraemia following dental extraction, tooth brushing and chewing. Cardiovasc. J. Afr., 2012, 23(6), 340-344.
35. Crasta,K.; Daly, C.G.; Mitchell, D.; Curtis, B.; Stewart, D.; Heitz-Mayfield, L.J. Bacteraemia due to dental flossing. J. Clin. Periodontol., 2009, 36(4), 323-332.
36. Zhang, W.; Daly, C.G.; Mitchell, D.; Curtis, B. Incidence and magnitude of bacteraemia caused by flossing and by scaling and root planing. J. Clin. Periodontol., 2012, Epub 10.1111/jcpe.12029.
37. Hartzell, J.D.; Torres, D.; Kim, P.; Wortmann, G. Incidence of bacteremia after routine tooth brushing. Am. J. Med. Sci., 2005, 329(4), 178-180.
38. Van Amersfoort, E.S.; Van Berkel T.J.; Kuiper, J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin. Microbiol. Rev., 2003, 16(3), 379-414.
39. Assinger, A.; Laky, M.; Schabbauer, G.; Hirschl, A.M.; Buchberger, E.; Binder, B.R.; Volf, I. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. J. Thromb. Haemost,. 2011, 9(4), 799-809.
40. Gendron, R.; Grenier, D.; Maheu-Robert, L. The oral cavity as a reservoir of bacterial pathogens for focal infections. Microbes Infect., 2000, 2(8), 897-906.
41. Mojon, P.; Bourbeau, J. Respiratory infection: how important is oral health? Curr. Opin. Pulm. Med., 2003, 9(3), 166-170.
42. Aurell, C.A.; Wistrom, A.O. Critical aggregation concentrations of gram-negative bacterial lipopolysaccharides (LPS). Biochem. Biophys. Res. Commun., 1998, 253(1), 119-123.
43. Hurley, J.C. Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders. Crit. Care., 2012, 16(4), R148.
44. Ogawa, T.; Asai, Y.; Makimura, Y.; Tamai, R. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A. Front. Biosci., 2007, 12, 3795-3812.
45. Levels, J.H.; Abraham, P.R.; van den Ende, A.; van Deventer, S.J. Distribution and kinetics of lipoprotein-bound endotoxin. Infect. Immun., 2001, 69(5), 2821-2828.
46. Feghali, C.A.; Wright, T.M. Cytokines in acute and chronic inflammation. Front. Biosci., 1997, 1(2), d12-26.
47. Di Filippo, C.; Rossi, F.; D’Amico, M. Targeting polymorphonuclear leukocytes in acute myocardial infarction. Scientific World Journal., 2007, 2(7), 121-134.
48. Wahaidi, V.Y.; Kowolik, M.J.; Eckert, G.J.; Galli, D.M. Endotoxemia and the host systemic response during experimental gingivitis. J. Clin. Periodontol., 2011, 38(5), 412-417.
49. Brandtzaeg, P.; Kierulf, P.; Gaustad, P.; Skulberg, A.; Bruun, J.N.; Halvorsen, S.; Sørensen, E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis., 1989, 159(2), 195-204.
50. Pussinen, P.J.; Paju, S.; Mäntylä, P.; Sorsa, T. Serum microbialand host-derived markers of periodontal diseases: a review. Curr. Med. Chem., 2007, 14(22), 2402-2412.
51. Geerts, S.O.; Nys, M.; De, M.P.; Charpentier, J.; Albert, A.; Legrand, V.; Rompen, E.H. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J. Periodontol., 2002, 73(1), 73-78.
52. Jensen, S.B.; Theilade, E.; Jensen, J.S. Influence of oral bacterial endotoxin on cell migration and phagocytic activity. J. Periodontal. Res., 1966, 1(2), 129-140.
53. Pussinen, P.J. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler. Thromb. Vasc. Biol., 2007, 27(6), 1433-1439.
54. Daly, C.G.; Seymour, G.J.; Kieser, J.B. Bacterial endotoxin: a role in chronic inflammatory periodontal disease? J. Oral. Pathol., 1980, 9(1), 1-15.
55. Wilson, W.; Taubert, K.A.; Gewitz, M.; Lockhart, P.B.; Baddour, L.M.; Levison, M.; Bolger, A.; Cabell, C.H.; Takahashi, M.; Baltimore, R.S.; Newburger, J.W.; Strom, B.L.; Tani, L.Y. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee. J. Am. Dent. Assoc., 2008, 139(Suppl: 3S-24S).
56. Douglas, C.W.; Heath, J.; Hampton, K.K.; Preston, F.E. Identity of viridans streptococci isolated from cases of infective endocarditis. J. Med. Microbiol., 1993, 39(3), 179-182.
57. Wang, C.Y.; Wang, H.C.; Li, J.M.; Wang, J.Y.; Yang, K.C.; Ho, Y.K.; Lin, P.Y.; Lee, L.N.; Yu, C.J.; Yang, P.C.; Hsueh, P.R. Invasive infections of Aggregatibacter (Actinobacillus) actinomycetemcomitans. J. Microbiol. Immunol. Infect., 2010, 43(6), 491-497.
58. Geraci, J.E.; Wilson, W.R. Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases. Mayo. Clin. Proc., 1982, 57(3), 145-148.
59. Tang, G.; Kitten, T.; Munro, CL.; Wellman, G.C.; Mintz, K.P. EmaA, a potential virulence determinant of Aggregatibacter actinomycetemcomitans in infective endocarditis. Infect. Immun., 2008, 76(6), 2316-2324.
60. Westling, K.; Vondracek, M. Actinobacillus (Aggregatibacter) actinomycetemcomitans (HACEK) identified by PCR/16S rRNA sequence analysis from the heart valve in a patient with blood culture negative endocarditis. Scand. J. Infect. Dis., 2008, 40(11-12), 981-983.
61. Thoden van Velzen, S.K.; Abraham-Inpijn, L.; Moorer, W.R. Plaque and systemic disease: a reappraisal of the focal infection concept. J. Clin. Periodontol., 1984, 11(4), 209-220.
62. Akamatsu, Y.; Yamamoto, T.; Yamamoto, K.; Oseko, F.; Kanamura, N.; Imanishi, J.; Kita, M. Porphyromonas gingivalis induces myocarditis and/or myocardial infarction in mice and IL-17A is involved in pathogenesis of these diseases. Arch. Oral Biol., 2011, 56(11), 1290-1298.
63. Babu, N.C.; Gomes, A.J. Systemic manifestations of oral diseases. J. Oral Maxillofac. Pathol., 2011, 15(2), 144-147.
64. Olinde, K.D.; O’Connell, J.B. Inflammatory heart disease: pathogenesis, clinical manifestations, and treatment of myocarditis. Annu. Rev. Med., 1994, 45, 481-490.
65. MacKay, J.; Mensah, G.A.; Greenlund, K. The Atlas of Heart Disease and Stroke. World Health Organization: Geneva, 2004, 16-26.
66. Haynes, W.G.; Stanford, C. Periodontal disease and atherosclerosis: from dental to arterial plaque. Arterioscler. Thromb. Vasc. Biol., 2003, 23(8), 1309-1311.
67. Buhlin, K.; Gustafsson, A.; Pockley, A.G.; Frostegård, J.; Klinge, B. Risk factors for cardiovascular disease in patients with periodontitis. Eur. Heart J., 2003, 24(23), 2099-2107.
68. Beck, J.D.; Offenbacher, S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J. Periodontol., 2005, 76(11), 2089-2100.
69. Kornman, K.S.; Pankow, J.; Offenbacher, S.; Beck, J.; di Giovine, F.; Duff, G.W. Interleukin-1 genotypes and the association between periodontitis and cardiovascular disease. J. Periodontal Res., 1999, 34(7), 353-357.
70. De Toledo, A.; Nagata, E.; Yoshida, Y.; Oho, T. Streptococcus oralis coaggregation receptor polysaccharides induce inflammatory responses in human aortic endothelial cells. Mol. Oral Microbiol., 2012, 27(4), 295-307.
71. Ott, S.J.; El Mokhtari, N.E.; Musfeldt, M.; Hellmig, S.; Freitag, S.; Rehman, A.; Kühbacher, T.; Nikolaus, S.; Namsolleck, P.; Blaut, M.; Hampe, J.; Sahly, H.; Reinecke, A.; Haake, N.; Günther, R.; Krüger, D.; Lins, M.; Herrmann, G.; Fölsch, U.R.; Simon, R.; Schreiber, S. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation, 2006, 113(7), 929-937.
72. Wiedermann, C.J.; Kiechl, S.; Dunzendorfer, S.; Schratzberger, P.; Egger, G.; Oberhollenzer, F.; Willeit, J. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J. Am. Coll. Cardiol., 1999, 34(7), 1975-1981.
73. Brodala, N.; Merricks, E.P.; Bellinger, D.A.; Damrongsri, D.; Offenbacher, S.; Beck, J.; Madianos, P.; Sotres, D.; Chang, Y.L.; Koch, G.; Nichols, T.C. Porphyromonas gingivalis Bacteremia Induces Coronary and Aortic Atherosclerosis in Normocholesterolemic and Hypercholesterolemic Pigs. Arterioscler. Thromb. Vasc. Biol., 2005, 25(7), 1446-1451.
74. Detert, J.; Pischon, N.; Burmester, G.R.; Buttgereit, F. The association between rheumatoid arthritis and periodontal disease. Arthritis Res. Ther., 2010, 12(5), 218.
75. Kubota, T.; Inoue, Y.; Iwai, T.; Kurihara, N.; Huang, Y.; Umeda, M. Arterial thrombosis after intravenous infusion of oral bacterium in a rat model. Ann. Vasc. Surg., 2008, 22(3), 412-416.
76. Giacona, M.B.; Papapanou, P.N.; Lamster, I.B.; Rong, L.L.; D’Agati, V.D.; Schmidt, A.M.; Lalla, E. Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol. Lett., 2004, 241(1), 95-101.
77. Iwai, T. Periodontal bacteremia and various vascular diseases. J. Periodontal Res., 2009, 44(6), 689-694.
78. Viegi, G.; Pistelli, F.; Sherrill, D.L.; Maio, S.; Baldacci, S.; Carrozzi, L. Definition, epidemiology and natural history of COPD. Eur. Respir. J., 2007, 30(5), 993-1013.
79. Hujoel, P.P.; Drangsholt, M.; Spiekerman, C.; DeRouen, T.A. Periodontitis-systemic disease associations in the presence of smoking--causal or coincidental?. Periodontol., 2002, 30, 51-60.
80. Wang, Z.; Zhou, X.; Zhang, J.; Zhang, L.; Song, Y.; Hu, FB.; Wang, C. Periodontal health, oral health behaviours, and chronic obstructive pulmonary disease. J. Clin. Periodontol., 2009, 36(9), 750-755.
81. Si, Y.; Fan, H.; Song, Y.; Zhou, X.; Zhang, J.; Wang, Z. Association between periodontitis and chronic obstructive pulmonary disease in a chinese population. J. Periodontol., 2012, 83(10), 1288-1296.
82. Scannapieco, FA. Role of Oral Bacteria in Respiratory Infection. J. Periodontol., 1999, 70(7), 793-802.
83. Teng, Y.T. Periodontal health and systemic disorders. J. Can. Dent. Assoc., 2002, 68(3), 188-92.
84. Mojon, P. Oral health and respiratory infection. J. Can. Dent. Assoc., 2002, 68(6), 340-345.
85. Mantzouranis, E.C.; Rosen, F.S.; Colten, H.R. Reticuloendothelial clearance in cystic fibrosis and other inflammatory lung diseases. N. Engl. J. Med., 1988, 319(6), 338-343.
86. Marron, A.; Carratalà, J.; González-Barca, E.; Fernández-Sevilla, A.; Alcaide, F.; Gudiol, F. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin. Infect. Dis., 2000, 31(5), 1126-1130.
87. Tunkel, A.R.; Sepkowitz, K.A. Infections caused by viridans streptococci in patients with neutropenia. Clin. Infect. Dis., 2002, 34(11), 1524-1529.
88. Azarpazhooh, A.; Leake, J.L. Systematic review of the association between respiratory diseases and oral health. J. Periodontol., 2006, 77(9), 1465-1482.
89. Kim, C.H.; Younossi, Z.M. Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome. Cleve. Clin. J. Med., 2008, 75(10), 721-728.
90. Tomofuji, T.; Ekuni, D.; Yamanaka, R.; Kusano, H.; Azuma, T.; Sanbe, T.; Tamaki, N.; Yamamoto, T.; Watanabe, T.; Miyauchi, M.; Takata, T. Chronic administration of lipopolysaccharide and proteases induces periodontal inflammation and hepatic steatosis in rats. J. Periodontol., 2007, 78(10), 1999-2006.
91. Tomofuji, T.; Ekuni, D.; Sanbe, T.; Azuma, T.; Tamaki, N.; Irie, K.; Maruyama, T.; Yamamoto, T.; Watanabe, T.; Miyauchi, M.; Takata, T. Effects of improvement in periodontal inflammation by toothbrushing on serum lipopolysaccharide concentration and liver injury in rats. Acta Odontol. Scand., 2009, 67(4), 200-205.
92. Ashare, A.; Monick, M.M.; Powers, L.S.; Yarovinsky, T.; Hunninghake, G.W. Severe bacteremia results in a loss of hepatic bacterial clearance. Am. J. Respir. Crit. Care Med., 2006, 173(6), 644-652.
93. Furuta, M. Relationship between periodontitis and hepatic abnormalities in young adults. Acta Odontol. Scand., 2010, 68(1), 27-33.
94. Tarantino, G. Non-alcoholic fatty liver disease, obesity and other illnesses. Clin. Invest. Med., 2008, 31(5), E290-E295.
95. Yoneda, M.; Naka, S.; Nakano, K.; Wada, K.; Endo, H.; Mawatari, H.; Imajo, K.; Nomura, R.; Hokamura, K.; Ono, M.; Murata, S.; Tohnai, I.; Sumida, Y.; Shima, T.; Kuboniwa, M.; Umemura, K.; Kamisaki, Y.; Amano, A.; Okanoue, T.; Ooshima, T.; Nakajima, A. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterology, 2012, 12: 16.
96. Krishnan, M.; Krishnan, P.; Natarajan, S. Occurrence of Porphyromonas gingivalis fimA type II and prtC genotype among periodontitis patients. BMC Infectious Dis., 2012, 12(l1), 22.
97. Coresh, J.; Astor, B.C.; Greene, T.; Eknoyan, G.; Levey, A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis., 2003, 41(1), 1-12.
98. Vilela, E.M.; Bastos, J.A.; Fernandes, N.; Ferreira, A.P.; Chaoubah, A.; Bastos, M.G. Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease. Clinics (Sao Paulo). 2011, 66(4), 657-662.
99. Bastos, J.A.; Diniz, C.G.; Bastos, M.G.; Vilela, E.M.; Silva, V.L.; Chaoubah, A.; Souza-Costa, D.C.; Andrade, L.C. Identification of periodontal pathogens and severity of periodontitis in patients with and without chronic kidney disease. Arch. Oral Biol., 2011, 56(8), 804-811.
100. Brito, F.; Almeida, S.; Figueredo, C.M.; Bregman, R.; Suassuna, J.H.; Fischer, R.G. Extent and severity of chronic periodontitis in chronic kidney disease patients. J. Periodontal Res., 2012, 47(4), 426-430.
101. Ashby, D.R.; Gale, D.P.; Busbridge, M.; Murphy, K.G.; Duncan, N.D.; Cairns, T.D.; Taube, D.H.; Bloom, S.R.; Tam, F.W.; Chapman, R.S.; Maxwell, P.H.; Choi, P. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int., 2009, 75(9), 976-981.
102. Viallard, J.F.; Bonnet, S.; Couzi, L.; Deminière, C.; Miossec, V.; Mercié, P.; Aparicio, M.; Pellegrin, J.L. Glomerulonephritis caused by Actinobacillus actinomycetemcomitans mimicking c-ANCApositive vasculitis. Nephrol. Dial. Transplant., 2002, 17(4), 663-665.
103. Ardalan, M.R.; Ghabili, K.; Pourabbas, R.; Shoja, M.M. A causative link between periodontal disease and glomerulonephritis: a preliminary study. Ther. Clin. Risk Manag., 2011, 7, 93-98.
104. Dorn, B.R.; Burks, J.N.; Seifert, K.N.; Progulske-Fox, A. Invasion of endothelial and epithelial cells by strains of Porphyromonas gingivalis. FEMS Microbiol. Lett., 2000, 187(2), 139-144.
105. Ford, E.S.; Li, C.; Zhao, G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J. Diabetes., 2010, 2(3), 180-193.
106. Harris, M.I. Diabetes in America: epidemiology and scope of the problem. Diabetes Care, 1998, Suppl 3, C11-4.
107. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global Prevalence of Diabetes-Estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27(5), 1047-1053.
108. Takeda, M.; Ojima, M.; Yoshioka, H.; Inaba, H.; Kogo, M.; Shizukuishi, S.; Nomura, M.; Amano A. Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients. J. Periodontol., 2006, 77(1), 15-20.
109. Basta, G.; Schmidt, A.M.; De Caterina, R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc. Res., 2004, 63(4), 582-592.
110. Lalla, E.; Papapanou, P.N. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat. Rev. Endocrinol., 2011, 7(12), 738-748.
111. Iacopino, A.M. Periodontitis and diabetes interrelationships: role of inflammation. Ann. Periodontol., 2001, 6(1), 125-137.
112. Nishimura, F.; Kono, T.; Fujimoto, C.; Iwamoto, Y., Murayama, Y. Negative effects of chronic inflammatory periodontal disease on diabetes mellitus. J. of the International Acad. of Periodontology., 2000, 2(2), 49-55.
113. Chen, L.; Luo, G.; Xuan, D., Wei, B., Liu, F.; Li, J.; Zhang J. Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study. J. Periodontol., 2012, 83(4), 435-443.
114. Ou, L.; Li, R.F. Effect of periodontal treatment on glycosylated hemoglobin levels in elderly patients with periodontal disease and type 2 diabetes. Chin. Med. J.(Engl)., 2011, 124(19), 3070-3073.
115. Sun, W.L.; Chen, L.L.; Zhang, S.Z.; Wu, Y.M.; Ren, Y.Z.; Qin, G.M. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis. Intern. Med., 2011, 50(15), 1569-1574.
116. Majithia, V.; Geraci, S.A. Rheumatoid arthritis: diagnosis and management. Am. J. Med., 2007, 120(11), 936-939.
117. Moen, K.; Brun, J.G.; Valen, M.; Skartveit, L.; Eribe, E.K.; Olsen, I.; Jonsson, R. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin. Exp. Rheumatol., 2006, 24(6), 656-663.
118. Loyola-Rodriguez, J.P.; Martinez-Martinez, R.E.; Abud-Mendoza, C.; Patiño-Marin, N.; Seymour, G.J. Rheumatoid arthritis and the role of oral bacteria. J. Oral Microbiol. 2010, Epub 2: 10.3402/jom.v2i0.5784.
119. Lu, X.; Hagen, T.P.; Vaughan-Sarrazin, M.S.; Cram, P. The Impact of New Hospital Orthopaedic Surgery Programs on Total Joint Arthroplasty Utilization. J. Bone Joint Surg. Am., 2010, 92(6), 1353-1361.
120. Li, X.; Tronstad, L.; Olsen, I. Brain abscesses caused by oral infection. Dental Traumatology, 1999, 15(3), 95-101.
121. Kurtz, S.M.; Lau, E.; Ong, K.; Zhao, K.; Kelly, M.; Bozic, K.J. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin. Orthop. Relat. Res., 2009, 467(10), 2606-2612.
122. Otomo-Corgel, J.; Pucher, J.J.; Rethman, M.P.; Reynolds, M.A. State of the science: chronic periodontitis and systemic health. J. Evid. Based Dent. Pract., 2012, 12(3), 20-28.
123. Matthews, P.C.; Berendt, A.R.; McNally, M.A.; Byren, I. Diagnosis and management of prosthetic joint infection. BMJ., 2009, 338, b1773.
124. Portnof, J.E.; Israel, H.A.; Brause, B.D.; Behrman, D.A. Dental premedication protocols for patients with knee and hip prostheses. N. Y. State Dent. J., 2006, 72(3), 20-25.
125. Drangsholt, M.T. Current concepts review. Prophylactic use of antibiotics for procedures after total joint replacement. J. Bone Joint Surg. Am., 1998, 80(9), 1394-1395.
126. Høiby, N.; Bjarnsholt, T.; Givskov, M.; Molin, S.; Ciofu, O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents., 2010, 35(4) 322-332.
127. Bjerkan, G.; Witsø, E.; Nor, A.; Viset, T.; Løseth, K.; Lydersen, S., Persen, L.; Bergh, K. A comprehensive microbiological evaluation of fifty-four patients undergoing revision surgery due to prosthetic joint loosening. J. Med. Microbiol., 2012, 61(Pt 4), 572-581.
128. Barberán, J. Management of infections of osteoarticular prosthesis. Clin. Microbiol. Infect., 2006, 12(3), 93-101.
129. Témoin, S.; Chakaki, A.; Askari, A.; El-Halaby, A.; Fitzgerald, S.; Marcus, R.E.; Han, Y.W.; Bissada, N.F. Identification of oral bacterial DNA in synovial fluid of patients with arthritis with native and failed prosthetic joints. J. Clin. Rheumatol., 2012, 18(3) 117-121.
130. Debelian, G.J.; Olsen, I.; Tronstad, L. Systemic diseases caused by oral microorganisms. Dental Traumatology., 1994, 10(2), 57-65.
131. Anil, S.; Varma, S.V.; Preethanath, R.S.; Anand, P.S.; Aldosari, A.F. The Emerging Concepts on the Impact of Periodontitis on Systemic Health. Periodontal Diseases-A Clinician’s Guide., 2012, 131-164.
132. Shinoda, T.; Mizutani, H.; Kaneda, T.; Suzuki, M. Fever of unknown origin caused by dental infection. Report of a case. Oral Surg. Oral Med. Oral Pathol., 1987, 64(2), 175-178.
133. Patel, S.M.; Mo, J.H.; Walker, M.T.; Adley, B.; Noskin, G.A. Epidural abscess and osteomyelitis due to Actinobacillus actinomycetemcomitans. Diagn. Microbiol. Infect. Dis., 2004, 50(4), 283-285.
134. Welkerling, H.; Geissdörfer, W.; Aigner, T.; Forst, R. Osteomyelitis of the ulna caused by Porphyromonas gingivalis. J. Clin. Microbiol., 2006, 44(10), 3835-3837.
135. Rahamat-Langendoen, J.C.; van Vonderen, M.G.; Engström, L.J.; Manson, W.L.; van Winkelhoff, A.J.; Mooi-Kokenberg, E.A. Brain abscess associated with Aggregatibacter actinomycetemcomitans: case report and review of literature. J. Clin. Periodontol., 2011, 38(8), 702-706.
136. Kressin, N.R.; Boehmer, U.; Nunn, M.E.; Spiro, A. Increased preventive practices lead to greater tooth retention. J. Dent. Res., 2003, 82(3), 223-227.
137. Thornhill, M.H. Infective endocarditis: the impact of the NICE guidelines for antibiotic prophylaxis. Dent Update., 2012, 39(1), 6-10.
138. Termine, N.; Panzarella, V.; Ciavarella, D.; Lo Muzio, L.; D’Angelo, M.; Sardella, A.; Compilato, D.; Campisi, G. Antibiotic prophylaxis in dentistry and oral surgery: use and misuse. Int. Dent. J., 2009, 59(5), 263-270.
139. Guay, D.R. Antimicrobial prophylaxis in noncardiac prosthetic device recipients. Hosp Pract (Minneap)., 2012, 40(1), 44-74.
140. Antunes, H.S.; Ferreira, E.M.; de Faria, L.M.; Schirmer, M.; Rodrigues, P.C.; Small, I.A.; Colares, M.; Bouzas, L.F.; Ferreira, C.G. Streptococcal bacteraemia in patients submitted to hematopoietic stem cell transplantation: the role of tooth brushing and use of chlorhexidine. Med. Oral Patol. Oral Cir. Bucal., 2010, 15(2), e303-309.
141. Cabov, T.; Macan, D.; Husedzinović, I.; Skrlin-Subić, J.; Bosnjak, D.; Sestan-Crnek, S.; Perić, B.; Kovac, Z.; Golubović, V. The impact of oral health and 0.2% chlorhexidine oral gel on the prevalence of nosocomial infections in surgical intensive-care patients: a randomized placebo-controlled study. Wien Klin. Wochenschr., 2010, 122(13-14), 397-404.
142. Fine, D.H.; Furgang, D.; McKiernan, M.; Tereski-Bischio, D.; Ricci-Nittel, D.; Zhang, P.; Araujo, M.W. An investigation of the effect of an essential oil mouthrinse on induced bacteraemia: a pilot study. J. Clin. Periodontol., 2010, 37(9), 840-847.
143. Lamprecht G, Heininger A. Current aspects of sepsis caused by bacterial translocation. Zentralbl Chir., 2012, 137(3), 274-8.
144. Chen, S.J.; Liu, C.J.; Chao, T.F.; Wang, K.L.; Wang, F.D.; Chen, T.J.; Chiang, C.E. Dental Scaling and Risk Reduction in Infective Endocarditis: A Nationwide Population-Based Case-Control Study. Can. J. Cardiol. 2012.
145. Shapiro, S.; Meier, A.; Guggenheim, B. The antimicrobial activity of essential oils and essential oil components towards oral bacteria. Oral Microbiol. Immunol., 1994, 9(4), 202-208.
146. Takarada, K.; Kimizuka, R.; Takahashi, N.; Honma, K.; Okuda, K.; Kato, T. A comparison of the antibacterial efficacies of essential oils against oral pathogens. Oral Microbiol. Immunol., 2004, 19(1), 61-64.
147. Sreenivasan, P.; Gaffar, A. Antiplaque biocides and bacterial resistance: a review. J. Clin. Periodontol., 2002, 29(11), 965-974.
148. Matthijs, S.; Adriaens, P.A. Chlorhexidine varnishes: a review. J. Clin. Periodontol., 2002, 29(1), 1-8.
149. Fine D.H.; Furgang, D.; Markowitz, K.; Sreenivasan, P.K.; Klimpel, K.; De Vizio, W. The antimicrobial effect of a triclosan/copolymer dentifrice on oral microorganisms in vivo. J. Am. Dent. Assoc., 2006, 137(10), 1406-1413.
150. Addy, M.; Wright, R. Comparison of the in vivo and in vitro antibacterial properties of providone iodine and chlorhexidine gluconate mouthrinses. J. Clin. Periodontol., 1978, 5(3), 198-205.
151. Gusberti, F.A.; Sampathkumar, P.; Siegrist, B.E.; Lang, N.P. Microbiological and clinical effects of chlorhexidine digluconate and hydrogen peroxide mouthrinses on developing plaque and gingivitis. J. Clin. Periodontol., 1988, 15(1), 60-67.
152. Jenkins, S.; Addy, M.; Newcombe, R.G. A comparison of cetylpyridinium chloride, triclosan and chlorhexidine mouthrinse formulations for effects on plaque regrowth. J. Clin. Periodontol., 1994, 21(6), 441-444.
153. McMurry, L.M.; Oethinger, M.; Levy, S.B. Triclosan targets lipid synthesis. Nature., 1998, 394(6693), 531-532.